5-fluoropyrimidine has been researched along with Breast Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bocci, G; Kerbel, RS | 1 |
| Koh, M; Morimoto, K | 1 |
| Abe, K; Fujii, H; Igarashi, T; Imoto, S; Itoh, K; Ohtsu, T; Sasaki, Y; Wakita, H | 1 |
| Fujioka, A; Fukushima, M; Kitazato, K; Nakagawa, F; Nukatsuka, M; Ohshimo, H | 1 |
1 review(s) available for 5-fluoropyrimidine and Breast Neoplasms
| Article | Year |
|---|---|
Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect.
Topics: Administration, Metronomic; Alkylating Agents; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Female; Forecasting; Humans; Immunity, Cellular; Pyrimidines; Randomized Controlled Trials as Topic; Tubulin Modulators | 2016 |
3 other study(ies) available for 5-fluoropyrimidine and Breast Neoplasms
| Article | Year |
|---|---|
[Postoperative changes in serum lipid levels of breast cancer and adjuvant chemotherapy].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Cholesterol; Cholesterol, HDL; Fatty Acids, Nonesterified; Female; Goserelin; Humans; Lipids; Middle Aged; Phospholipids; Postoperative Period; Pyrimidines; Tamoxifen; Triglycerides | 2004 |
The confusion associated with breast cancer chemotherapy in Japan: the first year's experience at the Division of Oncology and Hematology, National Cancer Center Hospital East.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cancer Care Facilities; Chemotherapy, Adjuvant; Female; Humans; Japan; Middle Aged; Oncology Service, Hospital; Pyrimidines; Tamoxifen | 1995 |
[The antitumor activity of DPD inhibitory-fluoropyrimidine (DIF) and non-DIF alone or in combination with paclitaxel against orthotopically implanted human breast cancer].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dihydrouracil Dehydrogenase (NADP); Female; Floxuridine; Humans; Mice; Mice, Inbred ICR; Neoplasm Transplantation; Oxidoreductases; Paclitaxel; Pyrimidines; Tegafur; Uracil | 2002 |